Recent studies demonstrate the promise of RMP1-14, a recently created anti-mouse PD-1 antibody , for enhancing tumor immunotherapy . Unlike current approaches, RMP1-14 exhibits superior affinity to murine https://www.targetmol.com/compound/anti_mouse_pd_1_antibody_rmp1_14